Related Experiment Video
Updated: Jan 13, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Ozoralizumab-Induced Multifocal Demyelinating Neuropathy in a Patient With Rheumatoid Arthritis
Yuya Ikegawa1, Yuichi Hamada1, Naoki Hayakawa1
1Neurology, Sumitomo Hospital, Osaka, JPN.
Tumor necrosis factor-α (TNF-α) inhibitors can cause nerve damage. A case study suggests ozoralizumab, a TNF-α inhibitor, may also trigger demyelinating neuropathy, requiring treatment for recovery.
Area of Science:
- Neurology
- Rheumatology
- Immunology
Background:
- Tumor necrosis factor-α (TNF-α) inhibitors are known to induce demyelinating polyneuropathy.
- This adverse effect has not been previously reported with ozoralizumab.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management

